AAAAAA

   
Results: 1-10 |
Results: 10
Clinical, biologic, and behavioral predictors of early immunologic and virologic response in HIV-infected patients initiating protease inhibitors
Authors: Le Moing, V Chene, G Carrieri, MP Besnier, JM Masquelier, B Salamon, R Bazin, C Moatti, JP Raffi, F Leport, C
Citation: V. Le Moing et al., Clinical, biologic, and behavioral predictors of early immunologic and virologic response in HIV-infected patients initiating protease inhibitors, J ACQ IMM D, 27(4), 2001, pp. 372-376
Risks factors and prevention of Q fever endocarditis
Authors: Fenollar, F Fournier, PE Carrieri, MP Habib, G Messana, T Raoult, D
Citation: F. Fenollar et al., Risks factors and prevention of Q fever endocarditis, CLIN INF D, 33(3), 2001, pp. 312-316
Prenatal and perinatal determinants of neonatal seizures occurring in the first week of life
Authors: Arpino, C Domizio, S Carrieri, MP Brescianini, S Sabatino, G Curatolo, P
Citation: C. Arpino et al., Prenatal and perinatal determinants of neonatal seizures occurring in the first week of life, J CHILD NEU, 16(9), 2001, pp. 651-656
'Do HIV-infected injecting drug users over-report adherence to highly active antiretroviral therapy?' A comparison between patients' self-reports andserum protease inhibitor concentrations in the French Manif 2000 cohort study
Authors: Duran, S Solas, C Spire, B Carrieri, MP Fuzibet, JG Costagliola, D Lacarelle, B Moatti, JP
Citation: S. Duran et al., 'Do HIV-infected injecting drug users over-report adherence to highly active antiretroviral therapy?' A comparison between patients' self-reports andserum protease inhibitor concentrations in the French Manif 2000 cohort study, AIDS, 15(8), 2001, pp. 1075-1077
Impact of drug maintenance treatment on injection practices among French HIV-infected IDUs
Authors: Reynaud-Maurupt, C Carrieri, MP Gastaud, JA Pradier, C Obadia, Y Moatti, JP
Citation: C. Reynaud-maurupt et al., Impact of drug maintenance treatment on injection practices among French HIV-infected IDUs, AIDS CARE, 12(4), 2000, pp. 461-470
Evaluation of the SIMI system, an experimental computerised network for the surveillance of communicable diseases in Italy
Authors: Carrieri, MP Salmaso, S Bella, A D'Ancona, F Demicheli, V Marongiu, C Niglio, T Sellitri, C
Citation: Mp. Carrieri et al., Evaluation of the SIMI system, an experimental computerised network for the surveillance of communicable diseases in Italy, EUR J EPID, 16(10), 2000, pp. 941-947
Use of buprenorphine in HIV-infected injection drug users: negligible impact on virologic response to HAART
Authors: Carrieri, MP Vlahov, D Dellamonica, P Gallais, H Lepeu, G Spire, B Obadia, Y
Citation: Mp. Carrieri et al., Use of buprenorphine in HIV-infected injection drug users: negligible impact on virologic response to HAART, DRUG AL DEP, 60(1), 2000, pp. 51-54
Adherence to HAART in French HIV-infected injecting drug users: the contribution of buprenorphine drug maintenance treatment
Authors: Moatti, JP Carrieri, MP Spire, B Gastaut, JA Cassuto, JP Moreau, J
Citation: Jp. Moatti et al., Adherence to HAART in French HIV-infected injecting drug users: the contribution of buprenorphine drug maintenance treatment, AIDS, 14(2), 2000, pp. 151-155
Relationship between HIV-1 viral load and continued drug use in untreated infected injection drug users
Authors: Carrieri, MP Tamalet, C Vlahov, D Yahi, N Chesney, M Moatti, JP
Citation: Mp. Carrieri et al., Relationship between HIV-1 viral load and continued drug use in untreated infected injection drug users, ADDICT BIOL, 4(2), 1999, pp. 197-202
Access to antiretroviral treatment among French HIV infected injection drug users: the influence of continued drug use
Authors: Carrieri, MP Moatti, JP Vlahov, D Obadia, Y Reynaud-Maurupt, C Chesney, M
Citation: Mp. Carrieri et al., Access to antiretroviral treatment among French HIV infected injection drug users: the influence of continued drug use, J EPIDEM C, 53(1), 1999, pp. 4-8
Risultati: 1-10 |